Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market
Pharmaceuticals

Messenger Ribonucleic Acid (mRNA) Synthesis Raw Materials Market Growth Outlook 2026–2030 with Innovation Trends and Competitive Analysis

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market By The End Of 2030?

The messenger ribonucleic acid (mRNA) synthesis raw materials market size has experienced steady growth in recent years. It is forecast to expand from $3.03 billion in 2025 to $3.12 billion in 2026, achieving a compound annual growth rate (CAGR) of 3.0%. The market’s growth during the preceding period can be attributed to an increasing demand for vaccines, progress in molecular biology, greater research and development investments in synthetic biology, the rise of infectious disease outbreaks, and the creation of efficient transcription enzymes.

The messenger ribonucleic acid (mrna) synthesis raw materials market is anticipated to experience consistent expansion over the next few years, with its size projected to reach $3.65 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.0%. This projected increase in the market can be linked to factors such as the broadening application of mrna-based therapies, the adoption of automated platforms for mrna synthesis, a rise in personalized medicine endeavors, the proliferation of biotechnology manufacturing centers, and advancements in nucleotide modifications. Significant trends foreseen for this period involve the refinement of synthetic mrna, the creation of high-purity raw materials, the establishment of scalable in-vitro transcription processes, the standardization of the supply chain for mrna manufacturing, and stringent adherence to quality control and regulatory guidelines.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12336&type=smp

What Drivers Are Shaping The Future Growth Of The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?

The increasing prevalence of cancer and chronic disorders is anticipated to propel the expansion of the mRNA synthesis raw materials market going forward. Cancer is a condition where abnormal cells proliferate uncontrollably, invading adjacent tissues and potentially spreading to other parts of the body via the blood and lymph systems. Chronic illnesses are generally defined as conditions that last for a year or more, require ongoing medical treatment, restrict daily activities, or both. mRNA synthesis raw materials are utilized in drug discovery, vaccine development, and the production of RNA-based therapeutics, offering improved immunogenicity, higher efficiency, and a shorter production time suitable for treating cancer and chronic disorders. For instance, in January 2024, data released by the American Cancer Society, a US-based non-profit organization, indicates that the United States is projected to experience 2,001,140 new cancer cases and 611,720 cancer deaths in 2024, an increase compared to 1,958,310 cases and 609,820 deaths in 2023. Furthermore, in September 2025, according to the British Heart Foundation, a UK-based charity, more than 7.6 million people (over 4 million men and more than 3.6 million women) across the UK are living with cardiovascular disease, and projections suggest that, influenced by an aging population and enhanced survival rates, the number of affected individuals could rise by approximately 1 million by 2030 and about 2 million by 2040. Therefore, the growing incidence of cancer and chronic disorders is a key driver for the mRNA synthesis of raw materials.

Which Segment Classifications Shape The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?

The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented –

1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types

2) By Applications: Therapeutics Production, Vaccine Production, Other Applications

3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users

Subsegments:

1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents

2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides

3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA

4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials

How Are Trends Impacting The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?

Leading companies in the messenger ribonucleic acid (mRNA) synthesis raw materials market are prioritizing the establishment of strategic partnerships. This focus aims to bolster their technological capabilities, broaden their range of high-quality raw materials, and expedite the manufacturing of next-generation mRNA therapeutics. These strategic collaborations represent formal agreements between biotechnology firms, enzyme developers, and nucleic acid technology providers, with the goal of jointly creating advanced IVT enzymes, modified nucleotides, capping analogs, or other essential inputs that improve mRNA yield, purity, stability, and safety. For example, in September 2024, TriLink Biotechnologies, a US-based biotechnology company, formed a partnership with Alphazyme LLC, a US-based company specializing in custom molecular biology enzymes, to introduce the CleanScribe RNA Polymerase. This next-generation IVT enzyme significantly reduces double-stranded RNA formation by up to 85% during mRNA synthesis, thereby supporting the development of safer and more potent mRNA therapeutics.

Which Companies Are Expanding Their Footprint In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?

Major companies operating in the messenger ribonucleic acid (mrna) synthesis raw materials market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group Ltd., Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Integrated DNA Technologies Inc., LGC Biosearch Technologies, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc., Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.

Read the full messenger ribonucleic acid (mrna) synthesis raw materials market report here:

https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

Which Geographic Regions Are Influencing Demand In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?

North America was the largest region in the mRNA synthesis raw materials market in 2025. The regions covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12336&type=smp

Browse Through More Reports Similar to the Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market 2026, By The Business Research Company

Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

Gene Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report

Ribose Nucleic Acid Rna Based Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ribose-nucleic-acid-rna-based-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model